Excessive accumulation of extracellular matrix components, especially collagen, is an important etiology of cardiac and hepatic fibrosis [109], and treatment with DAPs significantly inhibits hepatic collagen deposition in mice and induces liver fibrosis via the TGF-β/Smad pathway [44]. Here, TGFB1 is linked to Hepatic fibrosis.